HOME >> BIOLOGY >> NEWS
K-State microbiologist secret agent in battle against E. coli, other foodborne pathogens

er things that come into the liquid," Fung said. "Those inhibitors can really hamper new technologies and interfere with polymerase chain reactions. So the less inhibitors in the food the better your sample."

Fung said scientists can do filtration on the samples to filter but with that process you still have the inhibitors in the liquid, which may in turn lead to false reads because the inhibitors will alter the PCR reaction.

"The less inhibitor the better," Fung said.

Where the stomacher pulverizes the sample, Fung said the pulsifier literally shakes pathogens into the liquid without breaking up the food extensively. In turn, the pulsified samples are much cleaner in terms of the turbidity and much easier to operate.

"This is the first step of testing in food microbiology -- to blend your food first," Fung said. "This method will give you the same number of pathogens but the liquid is much clearer.

Fung said while many people study pathogens in relation to meat and poultry contamination, but the study of contamination in vegetables is often neglected.

"We make zillions of salads and send to the grocery stores, but there is no control," Fung said. "The only control of little packages of salad is low temperatures but some pathogens can survive and grow in low temperatures."

As opposed to foods that are cooked, Fung said prepared salad mixes are just opened -- sometimes washed -- and dumped into a bowl and eaten.

"This is an interesting experiment," Fung said "From a scientific standpoint, we're going to find out how and why the organisms are shaken into the liquid. We will be an electron microscope and looking at lettuce leaves to find out the difference between the pulsified and the stomacher samples and see if they are giving the same numbers (of pathogens). Because of our previous data I think it will show that they are."


'"/>

Contact: Daniel Y.C. Fung
danfung@k-state.edu
785-532-1208
Kansas State University
14-Nov-2002


Page: 1 2

Related biology news :

1. K-State, other universities to study how climate affects plant evolution
2. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
3. K-State professor combines love of teaching, research to examine eye development
4. K-State researcher working to improve alternatives to equine antibiotics
5. K-State business researchers to help with major study on food supply veterinary medicine
6. K-State researchers share $1 million grant to study insect pests
7. K-State soil carbon sequestration research playing role in climate change efforts
8. K-State uses geographic tools to track plant pathogens
9. K-State professor to give paper on potential impact of ag bioterrorism
10. K-State scientists beetle chosen for national genome sequencing project
11. New science at K-State attracts $4.2 million from National Science Foundation

Post Your Comments:
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: